Saturday, May 18, 2013 Last update: 9:34 AM
Company Tech News as it Breaks
Ernst & Young
News articles for Ernst & Young:
Monday, April 22, 2013
- Biotech industry has "implementation gap" around demonstrating the value of products under developmentCHICAGO, April 23, 2013 /PRNewswire/ -- The global biotechnology industry continued on a path of recovery in 2012 as public companies in the sector achieved top- and bottom-line growth for the third straight year even while R&D spending remained under pressure at many companies. However, new survey research in Ernst ... read more
Wednesday, February 13, 2013
- Global technology M&A value declines 35% in 2012 but only 4% in fourth quarterNEW YORK, Feb. 13, 2013 /PRNewswire/ -- The aggregate value of technology mergers and acquisitions (M&A) declined 35% worldwide in 2012, to US$114.1b from US$175.7b in 2011, according to Ernst & Young's Global technology M&A update: October-December 2012 and year in review report [hyperlink to the report]. Deal value in ... read more
Sunday, January 6, 2013
- Big pharma will increasingly tap M&A to close $100 billion growth gap, but path to deals grows more complexSAN FRANCISCO, Jan. 7, 2013 /PRNewswire/ -- Big pharma companies are facing a widening "growth gap" that will increase pressure to drive growth through mergers and acquisitions (M&A). But big pharma's attempts to make deals will be challenged by its diminished resources and fiercer competition for attractive assets from ... read more